Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

  
 
  
Reply to this topic

PKS, PKS Holdings Ltd
nipper
post Posted: Yesterday, 12:26 PM
  Quote Post


Posts: 8,302
Thanks: 2669


In Reply To: nipper's post @ Feb 23 2021, 09:10 AM

QUOTE
and now a Capital raise and SPP at 35c.


Mirrabooka has just announced a 5.16% holding ... bought more in the raise
The trading price is hovering around 36c .... two weeks to decide to participate.




--------------------
"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne
 
nipper
post Posted: Feb 26 2021, 02:52 PM
  Quote Post


Posts: 8,302
Thanks: 2669


In Reply To: nipper's post @ Feb 23 2021, 09:10 AM

We should see a near term future (only two to three years away) in which health systems start to move from a world of post-discharge data classification to concurrent computer-assisted coding. This will empower real time data analysis and clinical decision support so that clinical and financial outcomes can be optimized.


PKS is well suited to transform the trusted client relationships it has built over the last two decades into long term development partnerships which will support such a fundamental change in the operating model of healthcare.


Automated coding will be one of the most important data innovations in this decade: it will empower rapid improvement in the sustainability of health services and it will be the foundation stone on which genomics can enter the mainstream of clinical medicine because it will solve the core problem of precision medicine: access to high quality real-time reference data that can support clinical interpretation of genetic variants.


Our growth strategy has three pillars:
+ rapid scale of our core services, together with new product functionality and expansion in Australian and international markets;
+ development of new complementary products and services, including near real time comprehensive benchmarking services that will support health services understand more about their financial and clinical performance;
+ acceleration in research and development to support automated coding services and the deployment of our best-inclass decision support products in clinical practice beyond pathology.



--------------------
"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne
 
nipper
post Posted: Feb 23 2021, 09:10 AM
  Quote Post


Posts: 8,302
Thanks: 2669


In Reply To: nipper's post @ Aug 19 2020, 01:35 PM

and now a Capital raise and SPP at 35c. Dilution looming, maybe because SPP capped at $1mill whereas those sophs can put in $11M. Mind you, only 4% under previous trades, so the upside is limited.





--------------------
"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne
 
nipper
post Posted: Aug 19 2020, 01:35 PM
  Quote Post


Posts: 8,302
Thanks: 2669


some steady buying of PKS over the last few days, and hitting an all time high of 26.5c today . No news, but I guess results are due soon.

Together with Alcidion ALC and newly floated Jayex JHL in this sector, I wonder of there is consolidation brewing?



--------------------
"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne
 
nipper
post Posted: Apr 21 2020, 02:25 PM
  Quote Post


Posts: 8,302
Thanks: 2669


PKS will acquire software-as-a-service healthcare business Pavilion Health, in an all scrip deal that values the target at $8.5 million. Pavilion shareholders will be issued 65.2 million new PKS shares as part of the deal, about 35 per cent of the company post acquisition.

Pavilion is a cloud-based software company that provides audit, risk and consulting software services to hospitals and health bodies. Its customers include 550 hospitals in Australia (owned by the likes of listed giant Ramsay Health Care and private player Healthscope). Established in 2007, Pavilion generated $4.37 million in sales in the 2019 financial year and earnings of $1.66 million.

PKS said it would be looking to combine its software products with Pavilion's to create a more compelling value proposition to potential customers and also facilitate cross-selling and upselling.

PKS offers its customers a clinical decision management system, which uses patient data and clinical expertise to deliver patient-specific reports, recommendations and alerts.



--------------------
"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne
 
nipper
post Posted: Oct 20 2019, 04:19 PM
  Quote Post


Posts: 8,302
Thanks: 2669


QUOTE
.... PKS has signed a new Software License and Support Agreement with ACT Pathology for its Clinical Decision Support Solution
RippleDownâ„¢.

ACT Pathology, a PKS customer since 2005 provides specialist pathology services at the Canberra Hospital, Calvary Public Hospital Bruce, University of Canberra Hospital, National Capital Private Hospital and in the community through collection centres located across Canberra.

The new agreement which commences on 1 October 2019 is for a 17-month period with an option to extend for an additional 12 months. The value of new agreement is estimated to be $700,000, GST inclusive, over the 29-month period

....I try to take an interest when dealing with medical intervention. A marked aversion, pushback to Technology seems to be an all-too-common reality from the health practitioners I encounter.

Don't rock the boat, it's all too hard, General Ignorance predominate. "Heads down, can't change the system, get paid and don't care". Milk the public teat




--------------------
"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne
 


nipper
post Posted: Jul 18 2019, 10:11 AM
  Quote Post


Posts: 8,302
Thanks: 2669


In Reply To: nipper's post @ Jul 10 2019, 11:23 AM

rising share price on rising volume for PKS over the last few days

(now 23c, and above IPO price of 20c a share ... seems to have escaped the 'early investor selling wobbles')




--------------------
"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne
 
nipper
post Posted: Jul 10 2019, 11:23 AM
  Quote Post


Posts: 8,302
Thanks: 2669


QUOTE
PKS Holdings Limited (PKS) is an Australian healthcare technology company.
It provides a proprietary subscription based Clinical Decision Support system called "RippleDown"; CDS is a health information technology system that is designed to provide health professionals with assistance in clinical decision making tasks.

PKS works with health organisations around the world to better capture, manage and leverage their human expertise to improve the performance of their business and deliver better patient outcomes. PKS supports health organisation capture critical information in an accurate, consistent and reliable manner, across multiple data sources, by applying clinical expertise to all data in real-time.

QUOTE
RippleDown has two components that address a number of the key issues faced by healthcare organisations: - RippleDown Auditor: that enables operational efficiencies through a reduction in data entry errors; and
- RippleDown Expert: that allows faster patient throughput, better patient outcomes and mitigates succession risk

listed in June 2019, at 20c. I notice Perennial, through IFL, has 5.4% and Mirrabooka bought in at IPO with 4.5%



--------------------
"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne
 
 



Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING